STANDARDAERO INC (SARO)

US85423L1035 - Common Stock

25.93  +0.45 (+1.77%)

Fundamental Rating

3

Taking everything into account, SARO scores 3 out of 10 in our fundamental rating. SARO was compared to 64 industry peers in the Aerospace & Defense industry. SARO may be in some trouble as it scores bad on both profitability and health. SARO has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year SARO was profitable.

1.2 Ratios

SARO has a Return On Assets of 0.34%. This is comparable to the rest of the industry: SARO outperforms 42.19% of its industry peers.
SARO has a Return On Equity (1.76%) which is comparable to the rest of the industry.
SARO's Return On Invested Capital of 6.23% is fine compared to the rest of the industry. SARO outperforms 60.94% of its industry peers.
Industry RankSector Rank
ROA 0.34%
ROE 1.76%
ROIC 6.23%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SARO has a Profit Margin of 0.41%. This is comparable to the rest of the industry: SARO outperforms 43.75% of its industry peers.
SARO's Operating Margin of 7.82% is fine compared to the rest of the industry. SARO outperforms 60.94% of its industry peers.
SARO has a worse Gross Margin (14.25%) than 73.44% of its industry peers.
Industry RankSector Rank
OM 7.82%
PM (TTM) 0.41%
GM 14.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

SARO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SARO remains at a similar level compared to 1 year ago.
Compared to 1 year ago, SARO has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 1.97 indicates that SARO is not a great score, but indicates only limited risk for bankruptcy at the moment.
SARO's Altman-Z score of 1.97 is on the low side compared to the rest of the industry. SARO is outperformed by 62.50% of its industry peers.
A Debt/Equity ratio of 2.91 is on the high side and indicates that SARO has dependencies on debt financing.
SARO has a worse Debt to Equity ratio (2.91) than 84.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.91
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACC0.6
WACC10.31%

2.3 Liquidity

A Current Ratio of 2.11 indicates that SARO has no problem at all paying its short term obligations.
SARO's Current ratio of 2.11 is in line compared to the rest of the industry. SARO outperforms 53.13% of its industry peers.
SARO has a Quick Ratio of 1.41. This is a normal value and indicates that SARO is financially healthy and should not expect problems in meeting its short term obligations.
SARO has a Quick ratio of 1.41. This is comparable to the rest of the industry: SARO outperforms 57.81% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.41

3

3. Growth

3.1 Past

The earnings per share for SARO have decreased strongly by -66.67% in the last year.
Looking at the last year, SARO shows a quite strong growth in Revenue. The Revenue has grown by 9.95% in the last year.
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
Revenue 1Y (TTM)9.95%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.21%

3.2 Future

SARO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 136.89% yearly.
SARO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.04% yearly.
EPS Next Y433.2%
EPS Next 2Y222.92%
EPS Next 3Y136.89%
EPS Next 5YN/A
Revenue Next Year16.1%
Revenue Next 2Y14.22%
Revenue Next 3Y13.04%
Revenue Next 5YN/A

3.3 Evolution

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 324.13, SARO can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of SARO indicates a slightly more expensive valuation: SARO is more expensive than 60.94% of the companies listed in the same industry.
SARO's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
The Price/Forward Earnings ratio is 30.77, which means the current valuation is very expensive for SARO.
65.63% of the companies in the same industry are more expensive than SARO, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.99. SARO is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 324.13
Fwd PE 30.77

4.2 Price Multiples

62.50% of the companies in the same industry are more expensive than SARO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.26

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SARO's earnings are expected to grow with 136.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y222.92%
EPS Next 3Y136.89%

0

5. Dividend

5.1 Amount

No dividends for SARO!.
Industry RankSector Rank
Dividend Yield N/A

STANDARDAERO INC

NYSE:SARO (12/26/2024, 11:09:31 AM)

25.93

+0.45 (+1.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Inst Owners14.19%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner Change27.98%
Market Cap8.67B
Analysts81.33
Price Target36.38 (40.3%)
Short Float %4.31%
Short Ratio3.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.62%
PT rev (3m)N/A
EPS NQ rev (1m)12.5%
EPS NQ rev (3m)N/A
EPS NY rev (1m)16.67%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 324.13
Fwd PE 30.77
P/S 1.74
P/FCF N/A
P/OCF N/A
P/B 7.45
P/tB N/A
EV/EBITDA 20.26
EPS(TTM)0.08
EY0.31%
EPS(NY)0.84
Fwd EY3.25%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS14.91
BVpS3.48
TBVpS-5.38
PEG (NY)0.75
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.34%
ROE 1.76%
ROCE 7.89%
ROIC 6.23%
ROICexc 6.3%
ROICexgc 16%
OM 7.82%
PM (TTM) 0.41%
GM 14.25%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 2.91
Debt/FCF N/A
Debt/EBITDA 5.78
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 1.41
Altman-Z 1.97
F-ScoreN/A
WACC10.31%
ROIC/WACC0.6
Cap/Depr(3y)33.13%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.61%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
EPS Next Y433.2%
EPS Next 2Y222.92%
EPS Next 3Y136.89%
EPS Next 5YN/A
Revenue 1Y (TTM)9.95%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.21%
Revenue Next Year16.1%
Revenue Next 2Y14.22%
Revenue Next 3Y13.04%
Revenue Next 5YN/A
EBIT growth 1Y25.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.81%
EBIT Next 3Y38.38%
EBIT Next 5YN/A
FCF growth 1Y-2.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.05%
OCF growth 3YN/A
OCF growth 5YN/A